Fig. 1From: Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in TaiwanCumulative hazard rate of thyroid dysfunction estimated by the Kaplan-Meier approach in patients treated with pegylated interferon/ribavirin and untreated patients in Taiwan, 2001–2013Back to article page